NCT01883206View on ClinicalTrials.gov

CMV Glycoprotein B (gB) Vaccine Long Term Antibody Response

CompletedOBSERVATIONAL
Enrollment

48

Participants

Timeline

Start Date

September 30, 2013

Primary Completion Date

February 29, 2016

Study Completion Date

February 29, 2016

Conditions
Viraemia
Trial Locations (1)

NW3 2QG

Royal Free Hospital, London

All Listed Sponsors
lead

University College, London

OTHER

NCT01883206 - CMV Glycoprotein B (gB) Vaccine Long Term Antibody Response | Biotech Hunter | Biotech Hunter